Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2003
06/05/2003US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030104987 Methods of using the hyaluronan receptor for endocytosis
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103982 Therapeutic using a bispecific antibody
06/05/2003US20030103968 Use of alpha specific antibody BIBH1 in the treatment of cancer
06/05/2003US20030103904 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
06/05/2003US20030103899 Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
06/05/2003US20030103898 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
06/05/2003US20030103897 Activation immunology response in cells
06/05/2003US20030103896 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
06/05/2003US20030103895 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
06/05/2003CA2468010A1 Benzazepine derivatives and their use as 5-ht ligands
06/04/2003EP1316320A1 Preparations for diagnosing extrapancreatic secretory function
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315689A1 Synthesis of 17f labeled fluoroalkanes
06/04/2003EP1315524A2 Coated implant
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/03/2003US6574495 Para-hydrogen labelled agents and their use in magnetic resonance imaging
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6572856 Classic complement pathway, C3 convertase
05/2003
05/30/2003WO2003044031A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
05/30/2003WO2003022308A3 Therapeutic insert and therapeutic method
05/30/2003WO2002070020A3 Polymer precursors of radiolabeled compounds, and methods of making and using the same
05/29/2003US20030101466 Method for screening for agents against cancer using an immunosuppression animal model
05/29/2003US20030100752 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis
05/29/2003US20030100596 Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
05/29/2003US20030100129 Multi-partite ligands and methods of identifying and using same
05/29/2003US20030099662 Proteins
05/29/2003US20030099640 Three-step pretargeting methods and compounds
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1109559C Method for preparing stents with radioactive surface coating
05/27/2003US6569865 Psychological disorders; Alzheimer's disease
05/27/2003US6569841 Administering a dextran that has been modified by covalent bonding of charged groups opposite that of a charged tumor
05/27/2003US6569451 Targeted polymerized liposome diagnostic and treatment agents
05/27/2003US6569403 Determining effects of external stimuli on the brain using PET
05/27/2003US6569402 Vitronectin receptor antagonist pharmaceuticals
05/22/2003WO2003015870A3 Radioactive implantable devices and their production methods
05/22/2003WO2002097116A3 Delivery system for nucleic acids
05/22/2003WO2002044144A3 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
05/22/2003WO2002017969A3 Reagents and methods for the diagnosis of cmv dissemination
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095923 System for imaging malignant tumors using carbon 13 with MRI
05/21/2003EP1312381A1 PREPARATIONS FOR MEASRUING GASTRIC pH VALUE AND METHOD OF MEASURING GASTRIC pH VALUE BY USING THE SAME
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311303A2 Novel radiotherapeutic formulations containing ?224 ra and a method for their production
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311301A2 Stable radiopharmaceutical compositions and methods for preparation thereof
05/21/2003EP1311300A1 Radioligand and binding assay
05/21/2003EP1311292A2 Vitronectin receptor antagonist pharmaceuticals
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311192A1 $g(in vivo) imaging
05/21/2003EP1268464A4 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof
05/21/2003EP1146912A4 Method for improved radiation therapy
05/21/2003EP0765166B1 Radiolabeled annexin-galactose conjugates
05/21/2003EP0711178B1 Blood pool imaging composition and method of its use
05/21/2003CN1418884A 99TcMN dimercaptosuccinate compound, its preparation process and application in nucleic medicine science
05/21/2003CN1108826C Pharmaceutical kit with 1-hydroxy ethylidene diphosphonate and its preparation and use
05/21/2003CN1108825C Medicinal box of Re-188-rhenium sulfide suspension and its preparing process
05/20/2003US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6565829 Psychological disorders; central nervous system disorders
05/20/2003US6565828 Bifunctional chelant for attaching diagnostic metals and therpeutic isotopes to target specific biomolecules; heavy metal detoxification
05/20/2003US6565827 Anticarcinogenic agents
05/15/2003WO2003040693A2 Peptides that home to tumor lymphatic vasculature and methods of using same
05/15/2003WO2003040287A2 Isotope-coded affinity tag
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092198 Site-specific labeling of disulfide-containing targeting vectors
05/15/2003US20030091505 Antiserotonine agents; central nervous system disorders
05/15/2003CA2466319A1 Isotope-coded affinity tag
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309627A1 Immunotherapy for chronic myelocytic leukemia
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0980274B1 Polymer-coated stents, processes for producing the same and their use for restenosis prevention
05/14/2003EP0794788B1 Hepatic-directed compounds and reagents for preparation thereof
05/14/2003EP0772633B1 Complexes for use in the diagnosis of vascular diseases
05/13/2003US6562319 4-(phenylamino)quinazolines
05/13/2003US6562318 Nerve adhesion molecule coupled to active substance; undergoes axonal transport following neuronal endocytosis when contacted with nerve terminus in vascularized innervated tissue
05/13/2003US6562317 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content
05/13/2003US6562316 Drug delivery system with two-step targeting
05/13/2003CA2203014C Diagnostic preparation for detection of heliobacter pylori
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003US20030087883 Therapeutic 5-HT ligand compounds
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030086941 For diagnosing and therapy of gastrin-dependent tumor
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 243